Tag Archive: VaccinesWork

Enesi Pharma’s ImplaVax^®-Enabled, Solid-Dose Modified Live Virus Vaccine Produces Neutralising Antibody and T-Cell Responses Equivalent to Liquid Vaccine Delivered via Needle and Syringe

September 29, 2020 8:00 am Published by Carol Lloyd Leave your thoughts

Study investigating potential of solid-dose vaccine for porcine reproductive and respiratory syndrome virus (PRRSV) conducted in collaboration with The Pirbright... read more

Enesi Pharma’s ImplaVax^® platform shortlisted in the Best Emerging Medtech Company Category at the OBN Awards 2020

September 9, 2020 2:00 pm Published by Carol Lloyd Leave your thoughts

OXFORD, UK – 9 September 2020 – Enesi Pharma announces that its proprietary ImplaVax® solid dose, needle-free device and formulation... read more

Enesi Pharma and University of Oxford collaborate to target plague with a novel ImplaVax^®-enabled adenovirus-based solid dose vaccine

April 9, 2019 9:00 am Published by Carol Lloyd Leave your thoughts

OXFORD, UK – 09 April 2019 – Enesi Pharma (“Enesi”), an innovative pharmaceutical company developing unique injectable solid dose drug-device... read more

Tag Archive: VaccinesWork

Enesi Pharma’s ImplaVax®-Enabled, Solid-Dose Modified Live Virus Vaccine Produces Neutralising Antibody and T-Cell Responses Equivalent to Liquid Vaccine Delivered via Needle and Syringe

Enesi Pharma’s ImplaVax® platform shortlisted in the Best Emerging Medtech Company Category at the OBN Awards 2020

Enesi Pharma and University of Oxford collaborate to target plague with a novel ImplaVax®-enabled adenovirus-based solid dose vaccine

Enesi Pharma’s ImplaVax^®-Enabled, Solid-Dose Modified Live Virus Vaccine Produces Neutralising Antibody and T-Cell Responses Equivalent to Liquid Vaccine Delivered via Needle and Syringe

Enesi Pharma’s ImplaVax^® platform shortlisted in the Best Emerging Medtech Company Category at the OBN Awards 2020

Enesi Pharma and University of Oxford collaborate to target plague with a novel ImplaVax^®-enabled adenovirus-based solid dose vaccine